LOS ANGELES , May 30, 2014 /PRNewswire/ -- Medbox, Inc. (OTCQB: MDBX) ( www.medbox.com ), a leader in providing ancillary services to the alternative medicine industry, dispensary consulting services, and patented medicine dispensing systems to medical and retail industries, commented today on the news that the U.S. House of Representatives voted to effectively end DEA intervention in legal medical marijuana operations.

The House passed the amendment late Thursday night, which restricts the Drug Enforcement Administration from targeting medical marijuana operations in states where it is legal.

The 219-189 decision came on a bipartisan appropriations amendment spearheaded by California Republican Rep. Dana Rohrabacher and California Democrat Sam Farr .

Rep. Earl Blumenauer , Democrat from Oregon , stated, "The conflicting nature of state and federal marijuana laws has created an untenable situation," according to the Huffington Post . "It's time we take the federal government out of the equation so medical marijuana business owners operating under state law aren't living in constant fear of having their doors kicked down in the middle of the night."

"We are pleased that the United States House of Representatives has voted to end federal interference with dispensary operations in those states where these activities are considered legal," said Dr. Bruce Bedrick , Chief Executive Officer of Medbox, Inc. "As the industry's leading proponent of sensible cannabis regulations, we are gratified to see that federal lawmakers now accept that individual states' regulatory agencies are best equipped to manage their own cannabis industries. We believe this is a big step forward for dispensary operators and those who provide products and services to this growing market."

Currently 22 states and the District of Columbia allow marijuana use for medicinal purposes. Five others don't allow smoking of the plant, but do allow CBD oil – an ingredient in marijuana that may treat epilepsy.

About Medbox, Inc.

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Headquartered in Los Angeles , Medbox, through its wholly owned subsidiary, Medicine Dispensing Systems, offers their patented systems, software and consulting services to pharmacies, alternative medicine dispensaries and local governments in the U.S. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. ( www.vaporfection.com ), the company offers an industry award winning medical vaporizer product. Medbox, through its newly established subsidiaries, is in development of the following ancillary services catered to the alternative medicine industry: merchant services and armored transport for cash deposits, cannabidiol research and development, real estate acquisitions and subsequent lease programs to alternative medicine dispensaries, and alternative medicine dispensary management services.

For more information on Medbox, please contact (800) 762-1452 or go online to: http://www.medbox.com . 

Forward-Looking Statements
The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.

Contact Information
Investor Relations:
Stephen Hart 
Hayden IR
hart@haydenir.com
917-658-7878

SOURCE Medbox, Inc.